Lam Research (NASDAQ: LRCX) revenue
Lam Research reported revenue of $23,233m for fiscal 2026, 26.0% more than in fiscal 2025 ($18,436m). Since fiscal 2017 its revenue has grown by 189.9%, an average growth of 12.6% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2026 | $23,233m | +26.0% | $8,200m | 35.3% |
| 2025 | $18,436m | +23.7% | $5,901m | 32.0% |
| 2024 | $14,905m | −14.5% | $4,264m | 28.6% |
| 2023 | $17,429m | +1.2% | $5,175m | 29.7% |
| 2022 | $17,227m | +17.8% | $5,382m | 31.2% |
| 2021 | $14,626m | +45.6% | $4,482m | 30.6% |
| 2020 | $10,045m | +4.1% | $2,674m | 26.6% |
| 2019 | $9,654m | −12.9% | $2,465m | 25.5% |
| 2018 | $11,077m | +38.2% | $3,213m | 29.0% |
| 2017 | $8,014m | — | $1,902m | 23.7% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Lam Research
- How much revenue did Lam Research make in fiscal 2026?
- Lam Research reported revenue of $23,233m for fiscal 2026, compared with $18,436m in fiscal 2025.
- How much has the revenue of Lam Research grown?
- Between fiscal 2017 and fiscal 2026 it went from $8,014m to $23,233m: 189.9% more, an average growth of 12.6% a year.
- What was the best year for revenue at Lam Research?
- Of its last 10 fiscal years, fiscal 2026, with $23,233m.
- Where do the figures for Lam Research come from?
- From the annual report (Form 10-K) that Lam Research files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Lam Research files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Lam Research: the Lam Research page · annual accounts · net income · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.